Lifecore Biomedical, Inc.
General ticker "LFCR" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $210.0M (TTM average)
Lifecore Biomedical, Inc. follows the US Stock Market performance with the rate: 58.1%.
Estimated limits based on current volatility of 1.6%: low 8.55$, high 8.82$
Factors to consider:
- Total employees count: 459 as of 2023
- Current price 43.4% above estimated high
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-26 to 2026-05-26
- 2024-05-26 to 2025-05-26 estimated range: [3.03$, 6.99$]
- 2025-05-26 to 2026-05-26 estimated range: [2.59$, 6.06$]
Financial Metrics affecting the LFCR estimates:
- Negative: with PPE of -12.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Inventory ratio change, % of -3.47 <= -0.75
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 3.54
- Positive: Industry inventory ratio change (median), % of -0.81 <= -0.18
- Positive: -14.20 < Investing cash flow per share per price, % of -10.25
Short-term LFCR quotes
Long-term LFCR plot with estimates
Financial data
| YTD | 2022-05-29 | 2023-05-28 | 2024-05-26 |
|---|---|---|---|
| Operating Revenue | $111.27MM | $103.27MM | $128.26MM |
| Operating Expenses | $123.06MM | $125.06MM | $137.10MM |
| Operating Income | $-11.79MM | $-21.80MM | $-8.84MM |
| Non-Operating Income | $-8.90MM | $-42.13MM | $18.36MM |
| Interest Expense | $15.55MM | $17.65MM | $18.09MM |
| R&D Expense | $7.84MM | $8.74MM | $8.57MM |
| Income(Loss) | $-20.69MM | $-63.93MM | $9.51MM |
| Taxes | $-5.21MM | $0.31MM | $0.18MM |
| Profit(Loss)* | $-116.72MM | $-99.56MM | $12.01MM |
| Stockholders Equity | $87.82MM | $-4.23MM | $11.31MM |
| Inventory | $36.00MM | $40.84MM | $39.98MM |
| Assets | $274.70MM | $253.54MM | $253.96MM |
| Operating Cash Flow | $-22.59MM | $-17.44MM | $0.26MM |
| Capital expenditure | $29.94MM | $21.48MM | $18.39MM |
| Investing Cash Flow | $79.96MM | $-4.81MM | $-18.39MM |
| Financing Cash Flow | $-57.02MM | $39.70MM | $7.51MM |
| Earnings Per Share** | $-3.96 | $-3.32 | $0.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.